Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2655${count})

  • Research Grant, 2022
    Developing a Strategy to Determine Why Melanoma and Parkinson's Disease Occur Together

    Study Rationale: Having melanoma increases the risk for Parkinson's disease (PD)—and vice versa. The cellular basis for this association is not known. To identify the key cellular events that enhance...

  • Expanding Biological Understanding of Parkinson's Disease, 2022
    Evaluating the Role of Miro1 in Mitochondrial Quality Control in Parkinson’s Disease

    Study Rationale: Growing evidence suggests that dysfunction is linked to Parkinson’s disease (PD). These structures supply cells with energy, but must be eliminated when they become damaged — a...

  • Research Grant, 2022
    Shoring Up a Medical Chemistry Approach to Treating Parkinson’s Disease: The Bridge Initiative

    Study Rationale: The proteins parkin and GCase show a strong genetic link to Parkinson’s disease (PD) and are key players of biological pathways often disrupted in the disorder. This connection makes...

  • Translational Pipeline Program, 2022
    Development of a Nurr1 Activator as a Novel Therapeutic for Parkinson’s Disease

    Study Rationale: Nurr1 is a protein that works in the nucleus of dopamine-producing nerve cells in the brain to keep these cells functioning normally. Emerging evidence suggests that impaired function...

  • Research Grant, 2022
    Parkinson’s Disease Treatment Evaluation and Access Strategy: Phase 1

    Study Rationale: Core funding programs at The Michael J. Fox Foundation (MJFF) have historically focused on research to understand, measure, and treat Parkinson’s disease (PD). MJFF is now seeking to...

  • Novel PET Tracer Development Program, 2022
    Discovery of Novel Radiolabeled Tracers for Imaging Microglia Associated with Neuroinflammation in Parkinson’s disease

    Study Rationale: Parkinson´s disease (PD) is associated with neuroinflammation and the activation of microglia, cells that belong to the brain’s immune system. A protein called Colony stimulating...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.